Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0785
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2615
    -0.0007 (-0.06%)
     
  • USD/JPY

    151.3300
    -0.0420 (-0.03%)
     
  • Bitcoin USD

    69,698.47
    -867.16 (-1.23%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Elanco Animal Health Reports Mixed Q2 Earnings

Elanco Animal Health (NYSE: ELAN) reported adjusted second-quarter earnings of 28 cents per share, which beat the analyst consensus estimate of 26 cents by 7.69%.

The company reported quarterly sales of $781.6 million, which missed the analyst consensus estimate of $782.88 million by 0.16%.

"We continue to be pleased with the delivery of our productivity agenda driving the significant increase in adjusted gross margin as a percent of sales. We are encouraged by the 9 percent constant currency growth in our targeted growth categories and continue to make strategic investments that advance all three pillars of our strategy," said CEO Jeff Simmons.

View more earnings on ELAN

Elanco Animal Health shares traded up 4.9% at $31.15 at time of publication. The stock has a 52-week high of $37.61 and a 52-week low of $28.

Related Links:

Sysco Reports Mixed Q4 Earnings

The Stars Group Reports Mixed Q2 Earnings, Cuts Guidance

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement